Reduced Intensity Allogeneic Stem Cell Transplantation for Follicular Lymphoma Results in An Improved Progression Free Survival When Compared to Autologous Stem Cell Transplantation. An Analysis from the Lymphoma Working Party of the EBMT

被引：0
|
作者：
Robinson, Stephen P. [1 ]
Canals, Carmen [2 ]
Blaise, Didier [3 ]
Thomson, Kirsty [4 ]
Foa, Robert [5 ]
Atienza, Arturo Iriondo [6 ]
Harousseau, Jean-Luc [7 ]
Cordonnier, Catherine [8 ]
Cook, Gordon [9 ]
Jouet, Jean-Pierre
Cahn, Jean-Yves [10 ]
Crawley, Charles [11 ]
Attal, Michel [12 ]
Trneny, Marek [13 ]
Tilly, H. [14 ]
Sureda, Anna [11 ]
机构：
[1] Univ Hosp Bristol, BMT Unit, Bristol, Avon, England
[2] EBMT, Lymphoma Working Party, Barcelona, Spain
[3] Inst J Paoli I Calmettes, F-13009 Marseille, France
[4] UCL, Dept Haematol, London, Herts, England
[5] Univ Roma La Sapienza, Dept Cellular Biolechnol & Hematol, Rome, Italy
[6] Hosp U Marques de Valdecilla, Santander, France
[7] Hop Hotel Dieu, Nantes, France
[8] Hop Henri Mondor, Hematol Clin, F-94010 Creteil, France
[9] St James Univ, BMT Off, Leeds, W Yorkshire, England
[10] CHU Grenoble, Dept Hematol, F-38043 Grenoble, France
[11] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[12] Hop Purpan, Toulouse, France
[13] Charles Univ Prague, Gen Hosp, Dept Med 1, Prague, Czech Republic
[14] Ctr Henri Becquerel, F-76038 Rouen, France
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [41] Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party
    Avivi, Irit
    Boumendil, Ariane
    Finel, Herve Herve
    Nagler, Arnon
    Bothello, Aida Sousa
    Ribera Santasusana, Josep Maria
    Vandenberghe, Elisabeth A.
    Afanasyev, Boris
    Bordessoule, Dominique
    Maria Moraleda, Jose
    Conde, Eulogio
    Pohlreich, David
    Dreger, Peter
    BLOOD, 2014, 124 (21)
  • [42] Rituximab in autologous stem cell transplantation for follicular lymphoma
    Schmitz, N
    ANTI-CANCER DRUGS, 2001, 12 : S21 - S24
  • [43] In the Era of Chemoimmunotherapy, Relapse Post Autologous Stem Cell Transplantation for Follicular Lymphoma Is Associated with Prolonged Overall Survival. an Analysis By the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Robinson, Stephen
    Finel, Herve
    Boumendil, Ariane
    Tilly, Herve
    Salles, Gilles
    Corradini, Paolo
    Cairoli, Roberto
    Pytlik, Robert
    Schouten, Harry C.
    Lewerin, Catharina
    Thieblemont, Catherine
    Metzner, Bernd
    Rambaldi, Alessandro
    Ringhoffer, Mark
    Lown, Robert
    Rossi, Giuseppe
    Bittenbring, Jorg Thomas
    Bloor, Adrian
    Illes, Arpad
    Feugier, Pierre
    Turlure, Pascal
    Mufti, Ghulam
    Heinicke, Thomas
    Peggs, Karl
    Poire, Xavier
    Dreger, Peter
    Montoto, Silvia
    BLOOD, 2017, 130
  • [44] Superior Survival with Allogeneic Compared to Autologous Stem Cell Transplantation in Patients with Aggressive T Cell Lymphoma
    Kamarajah, Sivesh Kathir Kathir
    Barmayehvar, Behrad
    Gondal, Ali Z.
    Malladi, Ram
    Chaganti, Sridhar
    BLOOD, 2016, 128 (22)
  • [45] Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party
    Bazarbachi, Ali
    Boumendil, Ariane
    Finel, Herve
    Mohty, Mohamad
    Castagna, Luca
    Blaise, Didier
    Peggs, Karl S.
    Afanasyev, Boris
    Diez-Martin, J. L.
    Corradini, Paolo
    Michonneau, David
    Robinson, Stephen
    Gutierrez Garcia, Gonzalo
    Bonifazi, Francesca
    Yakoub-Agha, Ibrahim
    Gulbas, Zafer
    Bloor, Adrian
    Delage, Jeremy
    Esquirol, Albert
    Malladi, Ram
    Scheid, Christof
    El-Cheikh, Jean
    Ghesquieres, Herve
    Montoto, Silvia
    Dreger, Peter
    Sureda, Anna
    CANCER, 2019, 125 (01) : 90 - 98
  • [46] Improved outcomes with allogeneic compared with autologous stem cell transplantation in aggressive T-cell lymphoma
    McIlroy, Graham
    Barmayehvar, Behrad
    Kamarajah, Sivesh K.
    George, Lindsay
    Gondal, Ali Z.
    Malladi, Ram
    Chaganti, Sridhar
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (04) : 514 - 516
  • [47] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) VS ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) AS FIRST TRANSPLANT PROCEDURE IN PATIENTS WITH WALDESTROM MACROGLOBULINEMIA. RESULTS OF A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY OF THE EBMT
    Sureda, A.
    Canals, C.
    Kyriakou, C.
    Gisselbrecht, C.
    Gramatzki, M.
    Kazmi, M.
    Cahn, J. Y.
    Milpied, N.
    Kolbe, K.
    Arcese, W.
    Corradini, P.
    Niederwieser, D.
    Jouet, J. P.
    Thomson, K.
    Hamladji, R. M.
    Indrak, K.
    Schmitz, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 201 - 202
  • [48] Allogeneic stem cell transplantation in angioummunoblastic T-cell lymphoma: a retrospective survey from the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)
    Kyriakou, C
    Canals, C
    Taghipour, G
    Finke, J
    Kolb, HJ
    Goldstone, AH
    Sureda, A
    Schmitz, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S27 - S27
  • [49] The Persistent Uncertainty of When to Recommend Allogeneic Stem Cell Transplantation in Follicular Lymphoma
    Sorigue, Marc
    Sancho, Juan-Manuel
    CANCER, 2018, 124 (16) : 3454 - 3455
  • [50] Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?
    Ritchie, David S.
    LEUKEMIA & LYMPHOMA, 2008, 49 (10) : 1852 - 1853
12345